His work has been applied to a number of biomedical applications, such as stroke diagnosis, diabetic retinopathy screening or neurodegenerative disease tracking and successfully translated to industry with two startups based on his methods. One, Hubble Telemedical, was acquired by Welch Allyn, another, nQ-Medical has raised significant investment. He has authored/co-authored more than 60 peer-reviewed articles which were featured by news outlet such as MIT Technology Review, Smithsonian magazine and others. He has received multiple awards including SBMI Dean's Excellence Award for Research and the 100k Singapore Challenge, with the judging panel uniquely composed by Nobel Prize, Turing award and Millennium Technology Prize winners. His research and lab have been supported by competitive grants from the National Institute of Health, Translational Research Institute for Space Health, foundations and private companies.